Persist AI merges AI with robotics in a high‑throughput cloud laboratory to revolutionize drug formulation. Its platform accelerates discovery and scale-up, cutting time from early-stage trials to commercial manufacturing. Backed by top investors like Y Combinator and Microsoft.